Gossamer Bio, Inc. - GOSS

About Gravity Analytica
Recent News
- 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
- 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
- 03.11.2025 - Leerink's Global Healthcare Conference 2025
- 03.11.2025 - Leerink's Global Healthcare Conference 2025
- 03.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 03.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 02.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 02.07.2025 - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 02.03.2025 - Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
- 02.03.2025 - Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Recent Filings
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.19.2025 - 8-K Current report
- 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors